Drug Profile
Research programme: anti-interleukin 21 monoclonal antibodies - Novo Nordisk
Alternative Names: Anti-IL-21 monoclonal antibody - ZymoGenetics; IL-21 mAb; IL-21 monoclonal antibody - ZymoGeneticsLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator ZymoGenetics
- Class Monoclonal antibodies; Proteins
- Mechanism of Action Immunomodulators; Inflammation mediator modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Inflammation
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (Parenteral)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Inflammation in USA (Parenteral)
- 13 Oct 2010 ZymoGenetics has been acquired by Bristol-Myers Squibb